InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Marques Tiago, Chief Executive Officer. Director active across 1 company, notably Pasithea Therapeutics Corp.. Aggregated, 6 disclosures have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €22k. Activity tracked since 20 December 2021. The latest transaction was filed on 28 November 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Marques Tiago is President and Chief Executive Officer. Across 6 filings in total, the 6 sampled filings run from 2021-12-22 to 2025-12-01 and concern Pasithea Therapeutics Corp.; the observed volumes in this sample are EUR 21552 of buying and EUR 714 of selling, with the transaction nature indicated as Attribution.